Oxygenta Pharmaceutical quarterly results and financials

Oxygenta Pharmaceutical (BSE 524636)₹50.00+3.20%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Oxygenta Pharmaceutical reported sales of ₹37.03 Cr, up 144.6% from Jun 2025, and net profit of −₹2.11 Cr. For the year to Mar 2026, sales were ₹113 Cr and net profit −₹18.02 Cr.

Sales (Jun 2026): ₹37.03 Cr
Net profit (Jun 2026): −₹2.11 Cr
Sales (FY Mar 2026): ₹113 Cr
Net profit (FY Mar 2026): −₹18.02 Cr
EPS (Jun 2026): ₹−0.58
Borrowings (Mar 2026): ₹110 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Oxygenta Pharmaceutical quarterly results

₹ crore unless stated; each column is a quarter.

Oxygenta Pharmaceutical Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	13.09	9.16	10.56	12.63	14.02	33.20	49.50	15.14	14.29	33.95	49.60	37.03
Expenses	15.08	11.65	12.18	14.42	16.21	37.66	51.22	22.01	18.91	38.09	49.55	36.49
Operating Profit	−1.99	−2.47	−1.61	−1.77	−2.18	−4.35	−1.67	−6.84	−4.56	−4.09	0.11	0.54
OPM %	−15.2%	−27.1%	−15.4%	−14.1%	−15.5%	−13.2%	−3.4%	−45.1%	−32.0%	−12.1%	0.2%	1.5%
Other Income	−0.04	−0.03	0.25	0.03	0.76	0.50	−0.21	0.15	−0.05	0.00	0.16	0.03
Interest	0.35	0.37	0.60	0.42	0.70	0.40	2.14	0.64	0.96	1.40	1.82	2.47
Depreciation	0.82	0.68	0.63	0.64	0.65	0.70	−0.22	0.84	0.85	0.85	−0.23	0.61
Profit before tax	−3.17	−3.54	−2.58	−2.81	−2.76	−4.96	−3.79	−8.14	−6.43	−6.32	−1.27	−2.50
Tax %	−0.6%	6.5%	−409.2%	−51.4%	2.9%	−20.6%	−43.3%	−24.9%	−23.4%	−23.3%	32.9%	−15.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	−3.17	−3.79	8.04	−1.37	−2.86	−3.94	−2.16	−6.12	−4.94	−4.85	−1.71	−2.11
EPS (Rs)	−0.95	−1.14	2.41	−0.39	−0.81	−1.07	−0.59	−1.66	−1.34	−1.32	−0.47	−0.58

Oxygenta Pharmaceutical profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Oxygenta Pharmaceutical Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	11.99	8.01	13.01	21.02	14.01	52.04	61.04	30.99	40.04	109	113	135
Expenses	16.02	13.02	17.02	23.03	22.03	48.12	59.07	38.06	49.05	119	128	143
Operating Profit	−4.01	−5.01	−3.99	−1.99	−7.99	4.01	0.99	−7.01	−9.99	−9.99	−14.99	−8.00
OPM %	−34.0%	−59.0%	−31.0%	−10.0%	−57.0%	7.0%	2.4%	−23.0%	−24.0%	−9.0%	−14.0%	−5.9%
Other Income	0.00	1.01	0.99	0.00	4.01	2.01	0.99	−1.01	0.00	0.99	0.00	0.14
Interest	1.01	1.01	1.01	1.01	1.01	2.01	1.01	1.01	2.01	2.01	5.01	6.65
Depreciation	0.99	0.99	0.99	0.99	0.99	0.99	1.99	1.99	2.99	3.99	1.99	2.08
Profit before tax	−5.99	−5.99	−3.99	−2.99	−5.99	2.99	0.00	−10.98	−13.99	−13.98	−21.96	−16.52
Tax %	0.0%	2.0%	1.0%	−6.9%	−3.0%	7.1%	24.1%	2.0%	−74.9%	−27.9%	−20.9%	—
Exceptional items	0.00	0.00	0.00	0.00	3.99	1.99	0.00	−0.99	0.00	0.00	0.00	0.00
Net Profit	−6.01	−6.01	−5.01	−3.01	−6.01	3.01	−1.01	−12.03	−3.01	−10.02	−18.02	−13.61
EPS (Rs)	−5.40	−5.71	−4.45	−3.20	−5.69	2.88	−0.44	−8.17	−1.05	−2.80	−4.76	−3.71
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Oxygenta Pharmaceutical balance sheet

₹ crore, at each year end.

Oxygenta Pharmaceutical Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.99	10.01	10.01	9.99	9.99	10.01	10.01	14.00	14.01	33.02	37.01	37.01
Reserves	−26.05	−32.07	−38.07	−42.07	−45.07	−51.11	−48.14	−49.09	−60.11	−54.09	−63.13	−80.15
Borrowings	15.01	17.01	19.03	19.02	22.02	27.02	48.08	52.05	68.02	57.09	62.10	110
Other Liabilities	19.07	24.06	27.06	30.07	34.08	33.11	24.03	14.07	32.12	25.97	46.00	53.04
Total Liabilities	18.02	20.01	19.03	17.01	21.02	19.03	33.98	31.03	54.04	62.99	82.98	120
Fixed Assets	12.04	13.03	12.04	12.02	12.04	11.04	16.04	20.06	28.10	29.09	37.11	48.12
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.99	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	5.98	6.98	5.99	4.99	8.98	6.99	16.95	10.97	25.94	33.90	45.87	71.87
Inventories	0.54	0.94	1.89	1.55	5.34	4.26	12.12	7.29	11.70	13.73	20.52	29.41
Trade receivables	0.63	1.49	0.85	0.47	0.50	0.43	1.60	1.59	10.15	7.37	5.11	10.04
Cash & equivalents	0.09	0.02	0.03	0.02	0.01	0.13	0.46	0.15	0.10	0.09	0.13	2.14
Total Assets	18.02	20.01	19.03	17.01	21.02	19.03	33.98	31.03	54.04	62.99	82.98	120

Oxygenta Pharmaceutical cash flow

₹ crore, for each year.

Oxygenta Pharmaceutical Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−4.01	1.01	1.01	0.99	−8.01	−3.01	−2.01	−2.01	−2.01	−13.02	3.01	−28.02
Cash from investing activity	0.99	−1.99	−0.99	0.00	−0.99	0.00	−6.99	−4.99	−9.99	−3.99	−11.01	−13.99
Cash from financing activity	2.99	0.99	0.00	−0.99	7.99	2.99	8.99	5.99	10.98	16.98	7.98	42.91
Net cash flow	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex	2.31	2.09	0.92	0.42	0.58	0.53	6.76	4.96	9.66	4.12	11.42	12.89
Free cash flow	−6.99	−0.99	0.00	0.99	−7.99	−2.99	−7.99	−6.99	−10.99	−16.99	−7.99	−40.96
CFO / OP %	104.0%	−20.0%	−13.0%	−33.1%	395.9%	34.9%	−37.1%	−106.1%	22.9%	135.0%	−29.1%	182.0%

Oxygenta Pharmaceutical ratios

Working-capital days and returns, by year.

Oxygenta Pharmaceutical Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	37	43	38	13	8	10	10	9	119	67	16	31
Inventory days	85	42	123	58	122	101	122	57	179	150	79	106
Days payable	1,801	668	600	397	204	191	138	51	363	250	114	175
Cash conversion cycle	−1,679	−583	−440	−326	−74	−80	−6	15	−65	−33	−19	−38
Working capital days	−616	−454	−512	−438	−164	−275	−14	8	−94	−89	−184	−119
ROCE %	—	—	—	—	—	—	—	−1.0%	−47.0%	−42.0%	−33.0%	−34.0%

Oxygenta Pharmaceutical: frequently asked questions

What are the latest quarterly results of Oxygenta Pharmaceutical?

For the Jun 2026 quarter, Oxygenta Pharmaceutical reported sales of ₹37.03 Cr, up 144.6% year on year and net profit of −₹2.11 Cr. The operating margin was 1.5%.

What is the annual revenue of Oxygenta Pharmaceutical?

Oxygenta Pharmaceutical's sales for the year to Mar 2026 were ₹113 Cr; over the last twelve months they were ₹135 Cr.

What is the net profit of Oxygenta Pharmaceutical?

Net profit for the year to Mar 2026 was −₹18.02 Cr, and −₹13.61 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−3.71.

How much debt does Oxygenta Pharmaceutical have?

Oxygenta Pharmaceutical reported borrowings of ₹110 Cr at Mar 2026, against cash and equivalents of ₹2.14 Cr.

What is the free cash flow of Oxygenta Pharmaceutical?

Cash from operations was −₹28.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹40.96 Cr.

Loading…